Evidence map›Paper›PMID 36975711›Full record

ArticleGels (Basel, Switzerland)2023

Injectable Chitosan-Based Hydrogels for Trans-Cinnamaldehyde Delivery in the Treatment of Diabetic Foot Ulcer Infections.

Henry Chijcheapaza-Flores, Nicolas Tabary, Feng Chai, Mickaël Maton, Jean-Noel Staelens, Frédéric Cazaux, Christel Neut, Bernard Martel, Nicolas Blanchemain, Maria José Garcia-Fernandez

Open access · goldFull text read
In one paragraph

Article in Gels (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Henry Chijcheapaza-FloresUniv. Lille, INSERM, CHU Lille, U1008-Advanced Drug Delivery Systems and Biomaterials, F-59000 Lille, France.ORCID 0000-0002-7555-0109
Nicolas TabaryUniv. Lille, CNRS, INRAE, Centrale Lille, UMR 8207-UMET-Unité Matériaux et Transformations, F-59000 Lille, France.ORCID 0000-0001-9237-0196
Feng ChaiUniv. Lille, INSERM, CHU Lille, U1008-Advanced Drug Delivery Systems and Biomaterials, F-59000 Lille, France.ORCID 0000-0002-1839-6221
Mickaël MatonUniv. Lille, INSERM, CHU Lille, U1008-Advanced Drug Delivery Systems and Biomaterials, F-59000 Lille, France.ORCID 0009-0002-8291-0296
Jean-Noel StaelensUniv. Lille, CNRS, INRAE, Centrale Lille, UMR 8207-UMET-Unité Matériaux et Transformations, F-59000 Lille, France.ORCID 0000-0002-7092-7165
Frédéric CazauxUniv. Lille, CNRS, INRAE, Centrale Lille, UMR 8207-UMET-Unité Matériaux et Transformations, F-59000 Lille, France.ORCID 0000-0001-8861-9905
Christel NeutUniv. Lille, INSERM, CHU Lille, U1286-INFINITE, F-59000 Lille, France.ORCID 0000-0002-2036-6152
Bernard MartelUniv. Lille, CNRS, INRAE, Centrale Lille, UMR 8207-UMET-Unité Matériaux et Transformations, F-59000 Lille, France.ORCID 0000-0001-5329-3028
Nicolas BlanchemainUniv. Lille, INSERM, CHU Lille, U1008-Advanced Drug Delivery Systems and Biomaterials, F-59000 Lille, France.ORCID 0000-0002-1947-1705
Maria José Garcia-FernandezUniv. Lille, INSERM, CHU Lille, U1008-Advanced Drug Delivery Systems and Biomaterials, F-59000 Lille, France.ORCID 0000-0003-1918-616X
Inserm · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic foot ulcers (DFU) are among the most common complications in diabetic patients and affect 6.8% of people worldwide. Challenges in the management of this disease are decreased blood diffusion, sclerotic tissues, infection, and antibiotic resistance. Hydrogels are now being used as a new treatment option since they can be used for drug delivery and to improve wound healing. This project aims to combine the properties of hydrogels based on chitosan (CHT) and the polymer of β cyclodextrin (PCD) for local delivery of cinnamaldehyde (CN) in diabetic foot ulcers. This work consisted of the development and characterisation of the hydrogel, the evaluation of the CN release kinetics and cell viability (on a MC3T3 pre-osteoblast cell line), and the evaluation of the antimicrobial and antibiofilm activity (

Indexed as

antimicrobial treatmentchitosancyclodextrinsdiabetic foot ulcersdrug deliveryhydrogels

Identifiers

PMID36975711
PMCPMC10048173
OpenAlexW4360615142

What OpenQuestion holds

Textfull text, public
LicenceCC BY
reference markers read4
measurements read59
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.